Piperacillin-induced immune hemolysis: new cases and a concise review of the literatureMAYER, Beate; YÜREK, Salih; SALAMA, Abdulgabar et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 5, pp 1135-1138, issn 0041-1132, 4 p.Article

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interactionWALSH, Thomas J; SHOHAM, Shmuel; PETRAITIENE, Ruta et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4744-4748, issn 0095-1137, 5 p.Article

Intervention study of the association of antibiotic utilization measures with control of extended-spectrum β-lactamase (ESBL)-producing bacteriaZHONGGUANG WEN; XIAOYANG WEI; YONGHONG XIAO et al.Microbes and infection. 2010, Vol 12, Num 10, pp 710-715, issn 1286-4579, 6 p.Article

Concentrations of piperacillin-tazobactam in human jaw and hip boneAL-NAWAS, Bilal; KINZIG-SCHIPPERS, Marion; SOERGEL, Fritz et al.Journal of cranio-maxillo-facial surgery. 2008, Vol 36, Num 8, pp 468-472, issn 1010-5182, 5 p.Article

Antibiotics and immunomodulation: effects of cefotaxime, amikacin, nezlocillin, piperacillin and clindamycinROSZKOWSKI, W; KO, H. L; ROSZKOWSKI, K et al.Medical microbiology and immunology. 1985, Vol 173, Num 5, pp 279-289, issn 0300-8584Article

In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulationJONES, Ronald N; FRITSCHE, Thomas R; MOET, Gary J et al.Diagnostic microbiology and infectious disease. 2008, Vol 61, Num 1, pp 76-79, issn 0732-8893, 4 p.Article

False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam : is it still an issue?PENACK, Olaf; REMPF, Patricia; GRAF, Barbara et al.Diagnostic microbiology and infectious disease. 2008, Vol 60, Num 1, pp 117-120, issn 0732-8893, 4 p.Article

Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeSADER, Helio S; HSIUNG, Andre; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3, pp 341-344, issn 0732-8893, 4 p.Article

Population Pharmacokinetic Analysis of Piperacillin in Burn PatientsSANGIL JEON; SEUNGHOON HAN; JONGTAE LEE et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3744-3751, issn 0066-4804, 8 p.Article

Inhibition of flucloxacillin tubular renal secretion by piperacillinLANDERSDORFER, Cornelia B; KIRKPATRICK, Carl M. J; KINZIG, Martina et al.British journal of clinical pharmacology. 2008, Vol 66, Num 5, pp 648-659, issn 0306-5251, 12 p.Article

Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panelsRHOMBERG, Paul R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 1, pp 67-69, issn 0732-8893, 3 p.Article

Synthesis and antibacterial activity of a modified nuclear analogue of piperacillinDRIVER, M. J; BENTLEY, P. H; DIXON, R. A et al.Journal of antibiotics (Tokyo. 1968). 1984, Vol 37, Num 3, pp 297-299, issn 0021-8820Article

Individualization of Piperacillin Dosing for Critically III Patients: Dosing Software To Optimize Antimicrobial TherapyFELTON, T. W; ROBERTS, J. A; LODISE, T. P et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 4094-4102, issn 0066-4804, 9 p.Article

In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed culturesDOS SANTOS, Kênia Valéria; DINIZ, Claudio Galuppo; COUTINHO, Simone Cristina et al.Journal of medical microbiology. 2007, Vol 56, Num 6, pp 798-802, issn 0022-2615, 5 p.Article

Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosaFONSECA, A. P; EXTREMINA, C; FONSECA, A. F et al.Journal of medical microbiology. 2004, Vol 53, Num 9, pp 903-910, issn 0022-2615, 8 p.Article

Hypersensitivity to piperacillinCABANAS, R; MUNOZ, L; LOPEZ-SERRANO, C et al.Allergy (Copenhagen). 1998, Vol 53, Num 8, pp 819-820, issn 0105-4538Article

Genetic toxicology evaluation of the novel semi-synthetic antibiotic piperacillinCHENG, M; MANANDHAR, M; IATROPOULOS, M. J et al.Arzneimittel-Forschung. 1986, Vol 36, Num 9, pp 1379-1383, issn 0004-4172Article

FROM PENICILLIN TO PIPERACILLIN. PROCEEDINGS OF A SYMPOSIUM HELD AT THE ZOOLOGICAL SOCIETY OF LONDON ON 15 OCTOBER 1981JACKSON D ED; PHILLIPS I ED.1982; J. ANTIMICROB. CHEMOTHER.; ISSN 0305-7453; GBR; DA. 1982; VOL. 9; SUPPL. B; 109; BIBL. DISSEM.Conference Paper

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolatesLOPEZ-CERERO, L; PICON, E; MORILLO, C et al.Clinical microbiology and infection. 2010, Vol 16, Num 2, pp 132-136, issn 1198-743X, 5 p.Article

Daily serum piperacillin monitoring is advisable in critically ill patientsBLONDIAUX, Nicolas; WALLET, Frédéric; FAVORY, Raphaël et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 5, pp 500-503, issn 0924-8579, 4 p.Article

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infectionsWASAN PATEL, Gita; PATEL, Nimish; LAT, Asma et al.Diagnostic microbiology and infectious disease. 2009, Vol 64, Num 2, pp 236-240, issn 0732-8893, 5 p.Article

Piperacillin penetration into tissue of critically ill patients with sepsis-Bolus versus continuous administration?ROBERTS, Jason A; ROBERTS, Michael S; ROBERTSON, Thomas A et al.Critical care medicine. 2009, Vol 37, Num 3, pp 926-933, issn 0090-3493, 8 p.Article

Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individualNEWMAN, Diane; SCHEETZ, Marc H; ADEYEMI, Oluwadamilola A et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 10, pp 1734-1739, issn 1060-0280, 6 p.Article

Piperacillin/tazobactam-induced paresthesiaeLAMBOURNE, Jonathan; KITCHEN, Joanne; HUGHES, Claudine et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 5, pp 977-979, issn 1060-0280, 3 p.Article

Monotherapy with Amikacin or Piperacillin-Tazobactum Empirically in Neonates at Risk for Early-Onset Sepsis: A Randomized Controlled TrialVISHAL VISHNU TEWARI; JAIN, Naveen.Journal of tropical pediatrics (1980). 2014, Vol 60, Num 4, pp 297-302, issn 0142-6338, 6 p.Article